The week ahead
|This week the difficulty of trying to pass President Biden's $1.8tn stimulus package through Congress is likely to become increasingly apparent. Many Senate republicans are already balking at the price tag and contents, adding more weight to the view of an eventual passage of a sub $1tn package of measures (see my explanation of why Republican support is needed). One of the most contentious issues is likely to be a federally mandated $15 minimum wage.
At least, the Senate won't be juggling the impeachment of Donald Trump, at the same time as debating administration nominations and President Biden's fiscal proposal, with the impeachment trial now scheduled for the week of February 8.
The contrast between US and European data at the end of last week was clear in the release of Markit purchasing managers indices (PMI) data. US PMI's registered strong flash readings for January, with both the manufacturing and services indices rising while in contrast the Eurozone composite PMI fell in January, sliding further into contraction. A disappointing UK retail sales report highlighted the pressure on the UK high street too.
The reality is that many developed economies are struggling into the new year, with a sharp increase in virus cases including new variants, slower than hoped for rollout of vaccines, and vaccine production shortages, all pointing to a later than expected recovery phase.
This week, the Federal Reserve FOMC meeting (Wed) will garner most attention in markets. A few Fed officials mentioned tapering recently, clearly rattling markets, as memories of the 2013 "taper tantrum" came back to the surface. After tamping down on any taper talk Fed Chair Powell is likely remain dovish even as he expresses some optimism on growth. Growth in Q4 will have looked weak and US Q4 GDP (Thu) will be in focus, with most components likely to have slowed. A plethora of earnings releases will continue this week including key releases from the likes of Microsoft, AMD, Tesla, Apple and Facebook.
A dovish FOMC will do no favours for the US dollar (USD), which came under renewed pressure last week. However, risk assets appear to be struggling a little and should risk appetite worsen it could boost the USD, especially given extreme short positioning in the currency. Emerging Market currencies will be particularly vulnerable if any rally in the USD is associated with higher US real yields.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.